Actavis delivers big Q1 sales boost, thanks to Forest, Allergan buys

Emily Wasserman

Spring is in the air, and is starting to see the fruits of last year's M&A. The company reported first-quarter earnings that beat expectations–and that took a 59% leap over last year–after acquiring Laboratories and .

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS